Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
X4 Pharmaceuticals
X4 Pharmaceuticals
(XFOR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Mavorixafor
waldenstrom macroglobulinemia
,
melanoma
,
healthy volunteers/patients
,
renal cell carcinoma
,
carcinoma
,
syndrome
,
neutropenia
Aspartame
neutropenia
Bevifimod
waldenstrom macroglobulinemia
,
renal cell carcinoma
,
carcinoma
Ag013736
renal cell carcinoma
,
carcinoma
Mk3475
melanoma
Asn100
ventilator-associated pneumonia
,
pneumonia
,
staphylococcal pneumonia
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use